You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 773 A phase I/II study to evaluate the safety, tolerability and preliminary efficacy of GLS-012 monotherapy and in combination with zimberelimab in patients with advanced melanoma (Triumph-01)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
773 A phase I/II study to evaluate the safety, tolerability and preliminary efficacy of GLS-012 monotherapy and in combination with zimberelimab in patients with advanced melanoma (Triumph-01)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023188012
Dec 202336012
Jan 202475019
Feb 20244207
Mar 20244803
Apr 20244804
May 20243402
Jun 20241203
Jul 20242403
Aug 20243804
Sep 20243404
Oct 202458016
Nov 20242804
Dec 20242408
Jan 20252409
Feb 20251005
Mar 2025006
Apr 2025001
May 2025008
Jun 2025009
Total7230139